Thu, September 6, 2012
Wed, September 5, 2012

Andrew Peters Maintained (BIIB) at Strong Buy with Increased Target to $160 on, Sep 6th, 2012

Andrew Peters of Deutsche Bank, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $150 to $160 on, Sep 6th, 2012.

Andrew has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $150 on, Wednesday, July 25th, 2012
  • Geoffrey Porges of "Leerink Swann" Initiated at Buy on, Monday, July 23rd, 2012